
CAS 918127-53-4
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 produits concernés.
Tigatuzumab
CAS :Tigatuzumab (CS-1008) is a humanized monoclonal antibody targeting DR5 and is a TRAIL-R2 agonist with antitumor activity that induces apoptosis in cancer cells.Degré de pureté :98.9% (SDS-PAGE); 96.6% (SEC-HPLC) - 98.9% (SDS-PAGE); 96.6% (SEC-HPLC)Couleur et forme :LiquidMasse moléculaire :144.6 (kDa)


